Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel
Journal cover image

Ceramide analogue B13 induces apoptosis and completely inhibits growth of liver metastases from colon cancer in vivo a new strategy for the treatment of metastatic liver disease.

Publication ,  Journal Article
Selzner, M; Morse, MA; Sindram, D; Bielawska, A; Hannun, YA; Clavien, PA
Published in: Hepatology
October 1, 1999

Duke Scholars

Published In

Hepatology

ISSN

0270-9139

Publication Date

October 1, 1999

Volume

30

Issue

4

Start / End Page

161A / 161A

Publisher

W B SAUNDERS CO

Related Subject Headings

  • Gastroenterology & Hepatology
  • 1107 Immunology
  • 1103 Clinical Sciences
  • 1101 Medical Biochemistry and Metabolomics
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Selzner, M., Morse, M. A., Sindram, D., Bielawska, A., Hannun, Y. A., & Clavien, P. A. (1999). Ceramide analogue B13 induces apoptosis and completely inhibits growth of liver metastases from colon cancer in vivo a new strategy for the treatment of metastatic liver disease. Hepatology, 30(4), 161A-161A.
Selzner, M., M. A. Morse, D. Sindram, A. Bielawska, Y. A. Hannun, and P. A. Clavien. “Ceramide analogue B13 induces apoptosis and completely inhibits growth of liver metastases from colon cancer in vivo a new strategy for the treatment of metastatic liver disease.Hepatology 30, no. 4 (October 1, 1999): 161A-161A.
Selzner M, Morse MA, Sindram D, Bielawska A, Hannun YA, Clavien PA. Ceramide analogue B13 induces apoptosis and completely inhibits growth of liver metastases from colon cancer in vivo a new strategy for the treatment of metastatic liver disease. Hepatology. W B SAUNDERS CO; 1999 Oct 1;30(4):161A-161A.
Journal cover image

Published In

Hepatology

ISSN

0270-9139

Publication Date

October 1, 1999

Volume

30

Issue

4

Start / End Page

161A / 161A

Publisher

W B SAUNDERS CO

Related Subject Headings

  • Gastroenterology & Hepatology
  • 1107 Immunology
  • 1103 Clinical Sciences
  • 1101 Medical Biochemistry and Metabolomics